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Mean and standard deviation age was higher in Females
(45.6 ± 15 years) versus Males (44.1 ± 14 years) p = 0.005.
Age adjusted differences in Females versus Males were
EPA (0.23 ± 0.23% vs. 0.26 ± 0.20%, p = 0.0001), DHA
(3.54 ± 1.36 vs. 3.73 ± 1.37, p = 0.0001), Omega-3 index
(3.76 + 1.44 vs. 3.99 + 1.47), p = 0.0001, AA (0.36 + 0.13 vs.
0.36 + 0.13, p = NS), and EPA/AA (0.70 ± 0.64 vs.
0.79 ± 0.66, p = 0.0002). 46.4% of females and 39.1% of
males had a blood omega-3 index <3.5% (p < 0.0002),
and 73.7% of females and 66.3% of males (p < 0.0001)
had an EPA/AA <0.75 suggesting increased CVD risk
which was evident significantly more in women com-
pared to men.
Conclusion: A large proportion of the Saudi population
may be at increased CVD risk due to low blood levels of
omega-3 fatty acids and low EPA/AA blood level ratio.
Femalesmay be at higher risk thanmales. Future research
will investigate the relationship of blood omega-3 blood
levels and CHD incidence in the Saudi population.
http://dx.doi:10.1016/j.jsha.2015.05.202
22. Joint effect of acute myocardial infarction on
lipoprotein(a), C- reactive protein and markers of
haemostasis
Syed Shahid Habib, Abdul Jalil Mohammad Abdul
Gader, Mohammad Ibrahim Kurdi, Zohair Al Aseri,
Mona Mohamed Soliman
Objectives: An issue of considerable interest is the rela-
tive contribution of each component of atherogenesis to
CAD risk. An integrated approach encompassing the
relationship between non traditional risk factors and
coagulation assembly needs further studies.This study
aimed at an integrated approach to study the joint
changes in lipoprotein(a) [Lp(a)], high sensitivity C-
reactive-protein (hsCRP) and haemostatic parameters
in patients with acute myocardial infarction(AMI) and
their correlation with clinical characteristics in these
patients.
Methods: This study was conducted at the departments
of physiology, emergency medicine and cardiology.
Serial blood samples were collected from 50 patients with
AMI on admission to the hospital (1st sample), after
3–4 days (post revascularization, 2nd sample) and at
2–3 months of follow up (3rd sample) and control group
of 22 healthy subjects. The relationship of these markers
were also studied with the presence and severity of CAD
assessed by vessel and Gensini scoring. Blood samples
were analyzed for lipids, Lp(a), hsCRP, fibrinogen,
total(TFPI-T) & free(TFPI-F) tissue factor pathway inhibi-
tor, plasminogen activator inhibitor-1 (PAI-1), and tissue-
plasminogen-activator (t-PA).
Results: Lp(a), hsCRP, fibrinogen, PAI-1, TFPI-T and
TFPI-F were significantly higher in AMI compared to
control subjects. Lp(a) significantly increased in 2nd sam-
ple by 19.5% (P < 0.05) and 3rdsample (15.14%). hsCRP
levels increased significantly by 82.6% (P < 0.001) in 2nd
sample and dropped in 3rd sample (39.4%). Among
markers of hemostasis PAI-1 was the only marker which
was significantly high in the first sample and dropped in
successively by 37.8 & 57.2% respectively. Lp(a),
hsCRP and TFPI-T were significantly related to Gensini
scores.
Conclusions: Acute myocardial infarction affects Lp(a),
hsCRP and hemostatic markers significantly. Lp(a),
hsCRP and TFPI-T related significantly to CAD severity.
While fibrinogen, PAI-1 and TFPI-F were related to the
presence of CAD but there was no relationship with its
severity.
http://dx.doi:10.1016/j.jsha.2015.05.203
23. Does the maximum allowable contrast dose
(MACD) predict the risk of contrast induced
nephropathy (CIN) in patients with chronic kid-
ney disease (CKD)
Rasha Abdulaziz Al-Harthi, Mounira Alqahtani,
Ahmed Alsaileek, Ali M. Alghamdi
Background: CIN is associated with high in-hospital
mortality. Some studies recommend the utilization of the
MACD formula to guide safe contrast dosing, however
the evidence supporting use of this measure is limited.
Objective: The purpose of this study was to determine if
MACD is helpful in predicting the risk of CIN in patients
with CKD.
Methods: 8670 patients who underwent coronary
angiography in our center with or without Percutaneous
Coronary Intervention (PCI) (2008–2013) were included.
Patients with CKD (n = 144) were selected. Patients in
shock, on intra aortic balloon pump, on prophylactic
hemofiltration or on dialysis were excluded.
Creatinine was measured 48–72 h post procedure. T-
test, Chi-Square and multiple regression were used to
compare those patients who developed CIN and those
who did not develop CIN. CIN was defined as an
increase in serum creatinine by P25% or 0.5mg/dL from
baseline within 48–72 h after contrast exposure.
Results: CIN occurred in 28 patients (19.4%). Only 8
(5.6%) of the 144 patients exceeded MACD and 2 of
these patients developed CIN. The use of biplane
angiography explains the lower contrast dose. For this
reason the impact of exceeding MACD could not be
evaluated. Primary PCI was associated with CIN
(p = 0.012; OR 5.1)).
Conclusion: Overall it is best to limit contrast dose to the
extent possible as this is a known risk factor, however
MACD is not a useful variable in a risk model for predict-
ing CIN in our population. Primary PCI was the only pre-
dictor of CIN in our population.
http://dx.doi:10.1016/j.jsha.2015.05.204
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